Responses of dendritic cells to TLR-4 stimulation are maintained in the elderly and resist the effects of CMV infection seen in the young

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 71, Issue 9, 2016, Pages 1117-1123

  Janssen, Nicole ^a   Derhovanessian, Evelyna ^a   Demuth, Ilja ^b   Arnaout, Fadel ^b   Steinhagen Thiessen, Elisabeth ^b   Pawelec, Graham ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Aging; Circulating myeloid dendritic cells; Cytokine production; Cytomegalovirus; Human; TLR4

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOLOGIC FACTOR; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ADULT; AGED; AGING; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; FEMALE; HUMAN; IMMUNOLOGY; IN VITRO STUDY; MALE; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; IN VITRO TECHNIQUES; INTERLEUKIN-6; MALE; MIDDLE AGED; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84989211614     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glv119     Document Type: Article

References (30)

1. Muller L, Fulop T, Pawelec G. Immunosenescence in vertebrates and invertebrates. Immun Ageing. 2013;10(1):12.
2. Collin M, McGovern N, Haniffa M. Human dendritic cell subsets. Immu-nology. 2013;140(1):22-30.
3. Schreibelt G, Tel J, Sliepen KHEWJ, et al. Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy. Cancer Immunol Immun. 2010;59(10):1573-1582.
4. Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis. 2000;31(2):578-585.
5. Panda A, Qian F, Mohanty S, et al. Age-associated decrease in TLR function in primary human dendritic cells predicts infuenza vaccine response. J Immunol. 2010;184(5):2518-2527.
6. Jing Y, Shaheen E, Drake RR, Chen NY, Gravenstein S, Deng YP. Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol. 2009;70(10):777-784.
7. Perez-Cabezas B, Naranjo-Gomez M, Fernandez MA, Grifols JR, Pujol-Borrell R, Borras FE. Reduced numbers of plasmacytoid dendritic cells in aged blood donors. Exp Gerontol. 2007;42(10):1033-1038.
8. Agrawal A, Agrawal S, Cao JN, Su H, Osann K, Gupta S. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoi-nositide 3-kinase-signaling pathway. J Immunol. 2007;178(11):6912-6922.
9. Agrawal A, Agrawal S, Gupta S. Dendritic cells in human aging. Exp Ger-ontol. 2007;42(5):421-426.
10. Della Bella S, Bierti L, Presicce P, et al. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol. 2007;122(2):220-228.
11. Narbutt J, Lesiak A, Zak-Prelich M, et al. The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the polish population. Cell Mol Biol Lett. 2004;9(3):497-509.
12. Shodell M, Siegal F P. Circulating, interferon-producing plasmacy-toid dendritic cells decline during human ageing. Scand J Immunol. 2002;56(5):518-521.
13. Balistreri CR, Colonna-Romano G, Lio D, Candore G, Caruso C. TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J Clin Immunol. 2009;29(4):406-415.
14. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol. 2002;169(9):4697-4701.
15. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seropreva-lence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202-213.
16. Sinclair J, Sissons P. Latency and reactivation of human cytomegalovirus. J Gen Virol. 2006;87(Pt 7):1763-1779.
17. Reeves MB, Sinclair JH. Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo. J Virol. 2013;87(19):10660-10667.
18. Bertram L, Bockenhoff A, Demuth I, et al. Cohort profile: the Berlin Aging Study II (BASE-II). Int J Epidemiol. 2013;43(3):703-712.
19. Lung TL, Saurwein-Teissl M, Parson W, Schonitzer D, Grubeck-Loeben-stein B. Unimpaired dendritic cells call be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine. 2000;18(16):1606-1612.
20. Agrawal A, Tay J, Ton S, Agrawal S, Gupta S. Increased reactivity of den-dritic cells from aged subjects to self-antigen, the human DNA. J Immunol. 2009;182(2):1138-1145.
21. Derhovanessian E, Maier AB, Beck R, et al. Hallmark features of immunose-nescence are absent in familial longevity. J Immunol. 2010;185(8):4618-4624.
22. Saurwein-Teissl M, Schonitzer D, Grubeck-Loebenstein B. Dendritic cell responsiveness to stimulation with infuenza vaccine is unimpaired in old age. Exp Gerontol. 1998;33(6):625-631.
23. Goodwin K, Viboud C, Simonsen L. Antibody response to infuenza vaccination in the elderly: a quantitative review. Vaccine. 2006;24(8):1159-1169.
24. De Donato S, Granoff D, Minutello M, et al. Safety and immunogenicity of MF59-adjuvanted infuenza vaccine in the elderly. Vaccine. 1999;17(23-24):3094-3101.
25. Conne P, Gauthey L, Vernet P, et al. Immunogenicity of trivalent subunit versus virosome-formulated infuenza vaccines in geriatric patients. Vaccine. 1997;15(15):1675-1679.
26. Franceschi C, Capri M, Monti D, et al. Infammaging and anti-infammag-ing: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;128(1):92-105.
27. Franceschi C, Campisi J. Chronic infammation (infammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(suppl 1):S4-S9.
28. Bartlett DB, Firth CM, Phillips AC, et al. The age-related increase in low-grade systemic infammation (infammaging) is not driven by cytomegalo-virus infection. Aging cell. 2012;11(5):912-915.
29. Kvale EO, Dalgaard J, Lund-Johansen F, et al. CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain effcient T cell-stimulatory capability upon infection. Blood. 2006;107(5):2022-2029.
30. Leng SX, Qu T, Semba RD, et al. Relationship between cytomegalovirus (CMV) IgG serology, detectable CMV DNA in peripheral monocytes, and CMV pp65(495-503)-specifc CD8(+) T cells in older adults. Age. 2011;33(4):607-614.